News from the FDA/CDC

New at-home test approved for chlamydia and gonorrhea


 

People who want to be tested for chlamydia and gonorrhea are now able to do so without leaving their homes.

Called Simple 2, it’s the first test approved by the Food and Drug Administration that uses a sample collected at home to test for an STD, other than tests for HIV. The test can be purchased over-the-counter in stores or ordered online and delivered in discreet packaging. A vaginal swab or urine sample is collected and then sent for laboratory testing using a prepaid shipping label.

The FDA issued the final needed approval on Nov. 15, and the product is already for sale on the website of the manufacturer, LetsGetChecked. The listed price is $99 with free shipping for a single test kit, and the site offers a discounted subscription to receive a kit every 3 months for $69.30 per kit.

Gonorrhea cases have surged 28% since 2017, reaching 700,000 cases during 2021, Centers for Disease Control and Prevention data show. Chlamydia has also been on the rise, up 4% from 2020 to 2021, with 1.6 million annual infections.

Previously, tests for the two STDs required that samples be taken at a health care location such as a doctor’s office. The Simple 2 test results can be retrieved online, and a health care provider will reach out to people whose tests are positive or invalid. Results are typically received in 2-5 days, according to a press release from LetsGetChecked, which also offers treatment services.

“This authorization marks an important public health milestone, giving patients more information about their health from the privacy of their own home,” said Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, in a statement. “We are eager to continue supporting greater consumer access to diagnostic tests, which helps further our goal of bringing more health care into the home.”

A version of this article first appeared on WebMD.com.

Recommended Reading

One in five men carries high-risk HPV in international study
MDedge ObGyn
Making one key connection may increase HPV vax uptake
MDedge ObGyn
‘Missed opportunities’ for accurate diagnosing of women with vaginitis
MDedge ObGyn
New Moderna vaccine to work against recent COVID variant
MDedge ObGyn
Antigen tests: After pandemic success, time for bigger role?
MDedge ObGyn
As U.S. syphilis cases rise, those at the epicenter scramble
MDedge ObGyn
Young women rate top sources for STI self-testing
MDedge ObGyn
New RSV vaccine will cut hospitalizations, study shows
MDedge ObGyn
Tech encourages HIV prevention among women
MDedge ObGyn
Test all perinatally exposed infants for HCV: CDC
MDedge ObGyn